Winslow Capital Management, LLC Abiomed Inc Transaction History

Winslow Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $6.24 Million - $7.76 Million	-25,734 Reduced 2.01%	1,251,859 $308 Million
Q2 2022 Aug 12, 2022	BUY	$224.73 - $338.64 $83.8 Million - $126 Million	373,057 Added 41.24%	1,277,593 $316 Million
Q1 2022 May 13, 2022	BUY	$277.25 - $366.29 $251 Million - $331 Million	904,536 New	904,536 $300 Million
Q1 2019 May 14, 2019	SELL	$276.39 - $362.25 $145 Million - $190 Million	-523,751 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$281.08 - $444.25 $147 Million - $233 Million	523,636 Added 455335.66%	523,751 $170 Million
Q3 2018 Nov 09, 2018	SELL	$354.53 - $449.75 $73,742 - $93,548	-208 Reduced 64.4%	115 $52,000
Q2 2018 Aug 13, 2018	SELL	$278.07 - $446.21 $218 Million - $350 Million	-784,769 Reduced 99.96%	323 $132,000
Q1 2018 May 14, 2018	BUY	$192.49 - $295.85 $151 Million - $232 Million	785,092 New	785,092 $228 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Winslow Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Winslow Capital Management, LLC with notifications on news.